两组基线匹配,ASV组和对照组的平均年龄分别为62.7岁和63.6岁,男性分别占89.3%和87.2%,LVEF平均值分别为33.1%和33.3%,CSA分别占25.9%和28.3%,AHI分别为43.3事件/小时和42.8事件/小时。两组以指南为导向药物治疗(guideline-directed medica...
目前尚无随机对照研究(RCT)证据支持治疗SA能减少心血管并发症及死亡。为此,ADVENT-HF研究(Effect of Adaptive Servo Ventilation on Survival and Hospital Admissions in Heart Failure)旨在探讨自适应伺服通气(adaptive servo-ventilation,ASV)是否可以改善HFrEF伴SA患者的心血管不良结局。 研究方法 ADVENT-HF研究入选HFrEF...
2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2022, 145(18):e8951032.[3].Effects of dapagliflozin in heart failure according to duration of...
2.Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Ci...
[3].Heidenreich PA, Bozkurt B, Aguilar D, etal. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2022, 145(18):e895-1032. ...
[2].Jishnu Malgieet al .Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study.Eur J Heart Fail .2024 May [3].2024ESC-Clinicalcharacteristicsandtreatmentpatternsofnewusersofdapagliflozinforheartfailurewithreducede...
[10]. Heidenreich PA, Bozkurt B, Aguilar D, etal. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2022, 145(18):e895-1032. ...
, rv・ ■ (Lltvitw CUNICAL PRACTICE GUIDELINE: FULL TEXT -重新定义了心力衰竭的分期和分类 2022 AHA/ACC/HFSA Guideline for -全面更新了管理策略及治疗方案 the Management of Heart Failure -更加强调心衰预防以及心衰专业团队 A Report d the American College of Cardioiogy/Amctian lleirt AuocutKin...
(2)主要依据:2022年12月发表的STRONG-HF研究[5]入选了1078例住院的急性心衰患者,分为强化治疗组和常规治疗组,前者在出院后2周内将指南指导的药物治疗(guideline directed medical theray,GDMT)滴定至靶剂量,并在出院后密切随访,主要终点为180天时心衰住院或全因死亡的复合终点。结果发现,180天时强化治疗组的主要...
heart failureguideline-directed therapiespharmacological therapiesThe 2013 (with updates in 2016 and 2017) American College of Cardiology/American Heart Association and 2016 European Society of Cardiology guidelines provide practical evidence-based clinical guidelines for the diagnosis and treatment of both ...